Module 2: Starting, Continuing or Switching DMTs - How COVID Impacted our Current Decision Making.

Return to Enrollment Page

OVERVIEW

This module will discuss considerations for starting, continuing or switching DMTs during COVID-19.

FACULTY

Alexander Gill, MD

Neuroimmunology and Neuroinfectious Disease Clinical 
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Dr. Alexander J. Gill is a neurologist in Baltimore, Maryland and is affiliated with Johns Hopkins Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice between 6-10 years.

LEARNING OBJECTIVES

1.
Apply this knowledge to help with DMT selection, continuation, holding, discontinuation, or switching in MS patients as a result of COVID infection or infection risk.